SEQTOR trial shows comparable PFS for STZ/5-FU followed by everolimus and the reverse sequence in advanced pancreatic NETs.
Omitting bolus 5-fluorouracil (5-FU) from combination chemotherapy for gastrointestinal (GI) cancers did not adversely affect survival and was associated with less toxicity, a review of a large ...
Key points A 75-year-old woman presented to the emergency department with acute confusion and lethargy on the third day of ...
June 17, 2009 (Orlando, Florida) — There is now an antidote for clinicians to use in the event of an overdose of the commonly used chemotherapy 5-fluorouracil (5-FU), according to a poster ...
Purple Biotech Ltd. announced a significant study revealing that their drug NT219, combined with 5-fluorouracil (5-FU), effectively inhibits colorectal cancer brain metastasis by targeting the IRS2 ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Administration of 5-FU bolus did not affect survival for ...
However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor. HealthDay News — Omission of 5-fluorouracil (5-FU) from the first-line ...
The FDA highlights increased toxicity risks in patients with DPD deficiency when using Xeloda and 5-FU, urging genetic testing before treatment. DPD deficiency leads to severe side effects from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results